Interim condensed consolidated statement of changes in equity - EUR (€) € in Thousands |
Total |
IPO |
RSUs |
Allego Holding shareholders |
PIPE financing |
Total |
Total
IPO
|
Total
RSUs
|
Total
Allego Holding shareholders
|
Total
PIPE financing
|
Share capital |
Share capital
IPO
|
Share capital
RSUs
|
Share capital
Allego Holding shareholders
|
Share capital
PIPE financing
|
Share premium |
Share premium
Allego Holding shareholders
|
Share premium
PIPE financing
|
Reserves |
Accumulated deficit |
Accumulated deficit
RSUs
|
Non-controlling interests |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning balance at Dec. 31, 2021 | € (76,651) | € (76,651) | € 1 | € 61,888 | € 4,195 | € (142,735) | € 0 | |||||||||||||||
| Changes in Stock Holders Equity [Roll Forward] | ||||||||||||||||||||||
| Loss for the period | (268,573) | (268,269) | (268,269) | (304) | ||||||||||||||||||
| Other comprehensive income/(loss) | (2,861) | (2,861) | (2,861) | |||||||||||||||||||
| Total comprehensive income/(loss) for the nine months | (271,434) | (271,130) | (2,861) | (268,269) | (304) | |||||||||||||||||
| Other changes in reserves | 0 | 0 | (503) | 503 | ||||||||||||||||||
| Equity contribution (Allego Holding shareholders) | € 101,931 | € 101,931 | € 28,311 | € 73,620 | ||||||||||||||||||
| Equity contribution (Spartan shareholders) | 87,597 | 87,597 | 1,789 | 85,808 | ||||||||||||||||||
| Equity contribution (PIPE financing) | € 132,690 | € 132,690 | € 1,800 | € 130,890 | ||||||||||||||||||
| Equity contribution (Private warrants exercise) | 13,854 | 13,854 | 160 | 13,694 | ||||||||||||||||||
| Share-based payment expenses | 81,184 | 81,184 | 81,184 | |||||||||||||||||||
| Non-controlling interests on acquisition of subsidiary | 1,259 | 1,259 | ||||||||||||||||||||
| Ending balance at Sep. 30, 2022 | 70,430 | 69,475 | 32,061 | 365,900 | 831 | (329,317) | 955 | |||||||||||||||
| Beginning balance at Dec. 31, 2022 | 27,758 | 27,013 | 32,061 | 365,900 | (6,860) | (364,088) | 745 | |||||||||||||||
| Changes in Stock Holders Equity [Roll Forward] | ||||||||||||||||||||||
| Loss for the period | (82,064) | (81,829) | (81,829) | (235) | ||||||||||||||||||
| Other comprehensive income/(loss) | (1,782) | (1,782) | (1,782) | |||||||||||||||||||
| Total comprehensive income/(loss) for the nine months | (83,846) | (83,611) | (1,782) | (81,829) | (235) | |||||||||||||||||
| Other changes in reserves | 0 | 0 | (1,433) | 1,433 | ||||||||||||||||||
| Share-based payment expenses | 8,233 | € 1 | € 0 | 8,233 | € 1 | € 0 | € 1 | € 80 | 8,233 | € (80) | ||||||||||||
| Transaction costs related to issuance of ordinary shares in exchange of Public Warrants | (972) | (972) | (972) | |||||||||||||||||||
| Ending balance at Sep. 30, 2023 | € (48,826) | € (49,336) | € 32,142 | € 364,928 | € (10,075) | € (436,331) | € 510 |
| X | ||||||||||
- Definition Changes in Stock Holders Equity No definition available.
|
| X | ||||||||||
- Definition Increase Decrease Through Exchange Of Ordinary Shares No definition available.
|
| X | ||||||||||
- Definition Increase decrease through other changes in reserves. No definition available.
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Subsidiaries [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from the conversion of convertible instruments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from the exercise of warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase in equity through the issue of equity instruments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cost related to the issuance of shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|